Skip to main content
logo
Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7649
-0.0028 (-0.36%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Evogene Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.858.515.641.680.93
Revenue Growth (YoY)
-54.73%50.90%236.72%80.11%-10.58%
Cost of Revenue
4.092.681.690.910.77
Gross Profit
-0.245.833.950.770.16
Selling, General & Admin
5.7610.879.6810.429.99
Research & Development
7.9916.6520.7820.7921.13
Other Operating Expenses
0.040.52--3.5-
Total Operating Expenses
13.7928.0430.4627.7131.12
Operating Income
-14.03-22.21-26.51-26.94-30.95
Interest Income
2.477.551.490.521.94
Interest Expense
-1.89-3.34-0.97-3.33-1.41
Other Non-Operating Income (Expense)
0.614.240.52-2.810.52
Total Non-Operating Income (Expense)
1.198.451.04-5.631.04
Pretax Income
-13.5-18.05-25.99-29.75-30.43
Provision for Income Taxes
00.01-0.030.090.01
Net Income
-8.49-16.49-23.88-26.64-27.79
Minority Interest in Earnings
0.66-1.57-2.08-3.21-2.65
Earnings From Discontinued Operations
5.67----
Net Income to Common
-8.49-16.49-23.88-26.64-27.79
Shares Outstanding (Basic)
86544
Shares Outstanding (Diluted)
86544
Shares Change (YoY)
38.21%24.14%10.80%2.44%43.59%
EPS (Basic)
-1.70-2.47-5.20-6.43-6.90
EPS (Diluted)
-1.70-2.47-5.20-6.43-6.90
Free Cash Flow
-13.64-20.33-22.36-24.85-25.56
Free Cash Flow Per Share
-1.73-3.57-4.87-6.00-6.32
Gross Margin
-6.25%68.48%70.00%45.73%17.53%
Operating Margin
-364.24%-260.96%-470.00%-1608.42%-3328.28%
Profit Margin
-553.49%-212.13%-460.18%-1781.73%-3273.66%
FCF Margin
-353.93%-238.82%-396.49%-1483.52%-2748.71%
EBITDA
-12.89-19.71-23.9-24.36-28.72
EBITDA Margin
-334.54%-231.54%-423.69%-1454.39%-3088.06%
EBIT
-14.03-22.21-26.51-26.94-30.95
EBIT Margin
-364.24%-260.96%-470.00%-1608.42%-3328.28%
Effective Tax Rate
-0.01%-0.05%0.13%-0.30%-0.04%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q